C4 Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CCCC)

CUSIP: 12529R107

Q3 2021 13F Holders as of 30 Sep 2021

Holder snapshot 6 signals
Share change
+2,258,477
SEC-reported price per share
$44.68
Number of holders
110
Value change
+$110,759,163
Number of buys
69
Number of sells
32
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
110,144,928

Security key

12529R107

Report period

Q3 2021

Institutions

110

Top holders

10

Ownership snapshot

Top reported holders of CCCC - C4 Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F Highest disclosed value: $134,137,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $134.14M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value Top 5
PRICE T ROWE ASSOCIATES INC /MD/ $134.14M
BlackRock Finance, Inc. $99.61M
PERCEPTIVE ADVISORS LLC $85.46M
RTW INVESTMENTS, LP $81.33M
Bain Capital Life Sciences Invest... $62.14M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$134,137,000
3,544,837 shares
— 30 Jun 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$99,610,000
2,632,424 shares
— 30 Jun 2021
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$85,464,000
2,258,566 shares
— 30 Jun 2021
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$81,327,000
2,149,228 shares
— 30 Jun 2021
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
—
denominator unverified
$62,141,000
1,642,209 shares
— 30 Jun 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$53,234,000
1,406,840 shares
— 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
110
Shares
34,491,766
Rows available
110
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
106
Q3 2021 holders
110
Holder diff
4
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .